Single-cell immunology of SARS-CoV-2 infection
2021 · Nature Biotechnology · 131 citations
https://doi.org/10.1038/s41587-021-01131-y
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
5.1K
Citations
30
h-index
62
i10-index
Lindsay N. Carpp is an academic researcher from Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa. The author has contributed to research in topics: HIV Research and Treatment & SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies. The author has an h-index of 30, co-authored 88 publications.
ORCID: 0000-0003-0333-5925Papers by this author
worksNeutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
2022 · Nature Medicine · 112 citations
https://doi.org/10.1038/s41591-022-01953-6
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
2019 · BMC Infectious Diseases · 40 citations
https://doi.org/10.1186/s12879-019-4049-5
Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
2017 · Tuberculosis · 29 citations
https://doi.org/10.1016/j.tube.2017.11.009
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
2023 · Nature Communications · 18 citations
https://doi.org/10.1038/s41467-023-43384-y
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
2024 · EBioMedicine · 13 citations
https://doi.org/10.1016/j.ebiom.2024.105320
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat